Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma

201432 citationsJournal Articlehybrid Open Access

Authors

Abolfazl Akbari · Tehran University of Medical Sciences

Saeid Amanpour · Motamed Cancer Institute

Samad Muhammadnejad · Tehran University of Medical Sciences

Mohammad Hossein Ghahremani · Tehran University of Medical Sciences

Seyed H. Ghaffari · Shariati Hospital

Ahmad Reza Dehpour · Tehran University of Medical Sciences

Gholam Reza Mobini

Abstract

Our data suggested that SD-208 could not significantly reduce tumor growth and angiogenesis in human colorectal cancer model at least using SW-48 cells.

Topics & Keywords

TGF-β signaling in diseases Pancreatic and Hepatic Oncology Research Gastric Cancer Management and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: DARU Journal of Pharmaceutical Sciences

Volume 22, Issue 1, pp. 47-47

DOI: 10.1186/2008-2231-22-47

Field-Weighted Citation Impact: 1.71